STEMI patients--the more you bleed, the more you die: a comparison between classifications

Area of Science:

• Cardiology
• Clinical Research
• Hemorrhagic Complications

Background:

• Hemorrhagic complications are frequent in acute coronary syndrome patients.
• Existing bleeding severity scales lack specific development for ST-segment elevation myocardial infarction (STEMI) patients post-primary percutaneous coronary intervention.
• There is a need for effective bleeding risk stratification in STEMI management.

Purpose of the Study:

• To evaluate the clinical impact of Thrombolysis In Myocardial Infarction (TIMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) bleeding classifications.
• To identify which classification better predicts in-hospital mortality in STEMI patients with major bleeding.
• To assess the utility of bleeding scales in the context of primary percutaneous coronary intervention.

Main Methods:

• Analysis of 991 STEMI patients from the Intensive Cardiac Care Florence STEMI Registry.
• Comparison of major bleeding event rates using TIMI and ACUITY classifications.
• Assessment of the association between bleeding classification and in-hospital mortality.

Main Results:

• Major bleeding occurred in 8.9% of patients by TIMI and 17.2% by ACUITY classification.
• A significant number of patients (82) classified with major bleeding by ACUITY did not meet TIMI criteria, forming a 'gray zone' with low mortality.
• TIMI classification identified a higher-risk subgroup within major bleeding events.

Conclusions:

• The TIMI bleeding classification is more effective than ACUITY in identifying STEMI patients at higher risk of early mortality after primary percutaneous coronary intervention.
• Dual antiplatelet therapy in STEMI patients requires careful bleeding risk assessment.
• Renal failure is an independent predictor of major bleeding in this patient population.